Manufacturer (Brand): Dragon Pharma
Chemical Substance: Adipotide
Strength: 10 mg
Unit: 1 VIAL
Adipotide (10 mg) from Dragon Pharma is a research-grade peptide developed for scientific investigation into metabolic pathways, adipose signaling, and targeted fat-cell activity. It is widely studied in laboratory settings for its unique mechanism involving pro-apoptotic targeting of adipose tissue vasculature. This compound is not approved for human use, and all information here applies strictly to research environments.
Scientific interest in Adipotide often focuses on:
Studies involving adipose tissue biology
Investigations on mitochondrial stress responses
Research on energy regulation and metabolic models
Preclinical analysis of peptide–receptor interactions
Study timelines may include:
Short-term acute exposure models
Multi-week metabolic observation cycles
Comparative groups testing different peptide concentrations
Protocols vary by laboratory and study design.
Potential research-observed properties include:
Targeting of adipose-vascular pathways
Modulation of metabolic activity
Influences on energy-use markers
These findings apply only to controlled scientific experiments.
No human interaction data exists.
Laboratory studies may compare Adipotide with:
Mitochondrial regulators
AMPK-modulating compounds
Other adipose-targeting agents
Excessive concentrations in animal models have shown:
Electrolyte imbalance
Kidney biomarker elevation
Reduced food intake
Highlights the importance of controlled research dosing.
Published preclinical results have shown varying effects on adipose cell pathways and metabolic markers. Outcomes depend heavily on experimental design and laboratory variables.
Researchers often note:
Purity and consistency are key factors
Stability of lyophilized peptide is important for accurate study replication
Adipotide 10 mg from Dragon Pharma is a high-purity research peptide designed strictly for scientific and laboratory investigation. Its unique metabolic-pathway profile has made it a topic of interest in preclinical studies, but it is not intended for human use. Proper handling, storage, and research-protocol compliance are essential.
Please log in to write Adipotide review.
Drug Class: Anabolic Androgenic Steroid Injection
Administration: Intramuscular Injection
Manufacturer (Brand): Kalpa Pharmaceuticals, India
Chemical Substance: Drostanolone Propionate
Strength: 100 mg/ml
Unit: 1 VIAL x 10 ml [Sterile Multiple Dose]
Common Dose: 300-500 mg/week; 8-10 weeks;
Goal: Cutting
Drug Class: Anabolic Androgenic Steroid Injection
Administration: Intramuscular Injection
Manufacturer (Brand): Kalpa Pharmaceuticals, India
Chemical Substance: Trenbolone Blend
Strength: 150 mg/ml
Unit: 1 VIAL x 10 ml [Sterile Multiple Dose]
Common Dose: 1ml/EOD; 4-8 weeks;
Goal: Cutting
Drug Class: Anabolic Androgenic Steroid Injection
Administration: Intramuscular Injection
Manufacturer (Brand): Kalpa Pharmaceuticals, India
Chemical Substance: Trenbolone Enanthate
Strength: 200 mg/ml
Unit: 1 VIAL x 10 ml [Sterile Multiple Dose]
Average Dose: 300 - 600mg/week; 8-12 weeks;
Goal: Bulking
Drug Class: Anabolic Androgenic Steroid Injection
Administration: Intramuscular Injection
Manufacturer (Brand): Kalpa Pharmaceuticals, India
Chemical Substance: Trenbolone Acetate
Strength: 100 mg/ml
Unit: 1 VIAL x 10 ml [Sterile Multiple Dose]
Dosage: 50-100mg/EOD; 6-10 weeks;
Goal: Cutting